Question: is this a 2) strong advice, 1) weak advice 0) no advice?

In this large-scale, real-life setting, patients with HER2-negative  MBC who received paclitaxel plus bevacizumab as first-line chemotherapy had a significantly better OS and PFS than those receiving paclitaxel.
user
This is no advice
assistant